慢性阻塞性肺疾病急性加重期住院患者的多重用药情况 - Suppr

Polypharmacy in patients hospitalised for acute exacerbation of COPD.

作者信息

Díez-Manglano Jesús, Barquero-Romero José, Mena Pedro Almagro, Recio-Iglesias Jesús, Cabrera-Aguilar Javier, López-García Francisco, Viu Ramón Boixeda, Soriano Joan B

机构信息

Internal Medicine Dept, Hospital Royo Villanova, Zaragoza, Spain Aragon Health Sciences Institute, Zaragoza, Spain

Internal Medicine Dept, Hospital Tierra de Barros, Almendralejo, Badajoz, Spain.

出版信息

Eur Respir J. 2014 Sep;44(3):791-4. doi: 10.1183/09031936.00014814. Epub 2014 May 15.

DOI:10.1183/09031936.00014814

PMID:24833769

Abstract

摘要

相似文献

Polypharmacy in patients hospitalised for acute exacerbation of COPD.慢性阻塞性肺疾病急性加重期住院患者的多重用药情况

Eur Respir J. 2014 Sep;44(3):791-4. doi: 10.1183/09031936.00014814. Epub 2014 May 15.

High-risk patients following hospitalisation for an acute exacerbation of COPD.因 COPD 急性加重而住院后的高危患者。

Eur Respir J. 2013 Oct;42(4):946-55. doi: 10.1183/09031936.00180312. Epub 2013 Jan 24.

Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score.用 CURB65 评分预测慢性阻塞性肺疾病急性加重期的早期死亡率。

Respirology. 2011 Jan;16(1):146-51. doi: 10.1111/j.1440-1843.2010.01866.x.

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.比较小颗粒与大颗粒吸入性糖皮质激素在慢性阻塞性肺疾病中的疗效。

Int J Chron Obstruct Pulmon Dis. 2014 Oct 17;9:1163-86. doi: 10.2147/COPD.S68289. eCollection 2014.

The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.以患者为中心的结局在慢性阻塞性肺疾病病程中的作用：长期研究如何增进我们的理解。

Am J Med. 2006 Oct;119(10 Suppl 1):63-72. doi: 10.1016/j.amjmed.2006.08.009.

The impact of weekends on outcome for acute exacerbations of COPD.周末对 COPD 急性加重的影响。

Eur Respir J. 2012 Jan;39(1):46-50. doi: 10.1183/09031936.00013211. Epub 2011 Jun 9.

[Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].[慢性阻塞性肺疾病患者急性加重的理解与识别]

Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Oct;34(10):1030-4.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.噻托溴铵对中度慢性阻塞性肺疾病患者预后的影响（UPLIFT）：一项随机对照试验的预设亚组分析

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后的院内死亡率。

Arch Intern Med. 2003 May 26;163(10):1180-6. doi: 10.1001/archinte.163.10.1180.

Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病（COPD）住院患者的营养状况与长期死亡率

Respir Med. 2007 Sep;101(9):1954-60. doi: 10.1016/j.rmed.2007.04.009. Epub 2007 May 25.

引用本文的文献

Prevalence and predictors of polypharmacy and comorbidities among patients with chronic obstructive pulmonary disease: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.沙特阿拉伯一家三级医院的横断面回顾性研究：慢性阻塞性肺疾病患者中药物滥用和合并症的流行情况及其预测因素。

BMC Pulm Med. 2024 Sep 14;24(1):453. doi: 10.1186/s12890-024-03274-5.

Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis.慢性阻塞性肺疾病不良事件信号与潜在的谷胱甘肽过氧化物酶 1 抑制剂相关：序列对称分析。

Drug Saf. 2024 Jan;47(1):59-70. doi: 10.1007/s40264-023-01374-5. Epub 2023 Nov 23.

Associations of medication regimen complexity with medication adherence and clinical outcomes in patients with chronic obstructive pulmonary disease: a prospective study.药物治疗方案的复杂性与慢性阻塞性肺疾病患者的药物依从性和临床结局的相关性：一项前瞻性研究。

Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231206249. doi: 10.1177/17534666231206249.

Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece.评估希腊呼吸疾病住院患者的药物相互作用。

Adv Respir Med. 2023 Feb 5;91(1):74-92. doi: 10.3390/arm91010008.

Factors associated with the identification of drug therapy problems among older patients in Primary Health Care.与初级保健中老年患者药物治疗问题识别相关的因素。

Einstein (Sao Paulo). 2022 Apr 8;20:eAO6544. doi: 10.31744/einstein_journal/2022AO6544. eCollection 2022.

When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.慢性阻塞性肺疾病（COPD）何时使用单吸入器三联疗法：基层医疗保健专业人员的实用方法

Int J Chron Obstruct Pulmon Dis. 2019 Feb 13;14:391-401. doi: 10.2147/COPD.S173901. eCollection 2019.

Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.慢性阻塞性肺疾病（COPD）代谢综合征（MetS）的病理生物学机制：临床意义和治疗策略。

Pharmacol Ther. 2019 Jun;198:160-188. doi: 10.1016/j.pharmthera.2019.02.013. Epub 2019 Feb 26.

A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD.一项针对社区居住的 COPD 患者的临床药师合作干预的非随机对照初步研究。

NPJ Prim Care Respir Med. 2018 Oct 10;28(1):38. doi: 10.1038/s41533-018-0105-7.

Diseases Linked to Polypharmacy in Elderly Patients.老年患者多重用药相关疾病

Curr Gerontol Geriatr Res. 2017;2017:4276047. doi: 10.1155/2017/4276047. Epub 2017 Dec 25.

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.慢性阻塞性肺疾病的多重疾病模式、多药治疗及药物不良反应风险研究：一项英国生物银行横断面研究

BMJ Open. 2018 Jan 14;8(1):e018404. doi: 10.1136/bmjopen-2017-018404.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Polypharmacy in patients hospitalised for acute exacerbation of COPD.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献